Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mexigliz M 60mg/500mg Tablet XR

Prescription Icon
Prescription Required

Marketer

Fugo Life Science Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Mexigliz M 60mg/500mg Tablet XR

Diabexe Duo 60mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Mexigliz M 60mg/500mg Tablet XR

No text provided. Please provide the text you wish me to rephrase.

Uses of Mexigliz M 60mg/500mg Tablet XR

Non-insulin-dependent diabetes

Major Benefits of Mexigliz M 60mg/500mg Tablet XR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Mexigliz M 60mg/500mg Extended-Release tablet should be taken with a meal.

Common Side effects of Mexigliz M 60mg/500mg Tablet XR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Mexigliz M 60mg/500mg Tablet XR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mexigliz M 60mg/500mg Extended-Release tablet should be taken with a meal.

How Mexigliz M 60mg/500mg Tablet XR works:

Extended-release Mexigliz M tablets (60mg/500mg) contain a dual-action formulation of gliclazide and metformin, both used in diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Mexigliz M 60mg/500mg XR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mexigliz M 60mg/500mg tablets pose a confirmed risk to fetal development and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Mexigliz M 60mg/500mg tablets are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Mexigliz M 60mg/500mg XR tablets. Dosage modification may be necessary; physician consultation is advised. Mexigliz M 60mg/500mg XR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Mexigliz M 60mg/500mg Extended-Release tablets cautiously. Dosage modification of Mexigliz M 60mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised. A low starting dose of Mexigliz M 60mg/500mg Extended-Release tablets is typically employed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Mexigliz M 60mg/500mg Tablet XR :

Should you forget to take a Mexigliz M 60mg/500mg extended-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mexigliz M 60mg/500mg Tablet XR

LabelValue
Developing Good Habits No.
Type of Treatment Diabetes Medication

FAQs on Mexigliz M 60mg/500mg Tablet XR

Mexigliz M 60mg/500mg XR tablets combine gliclazide and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mexigliz M 60mg/500mg Tablet XR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use can result in vitamin B12 deficiency.
Mexigliz M 60mg/500mg XR tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Mexigliz M 60mg/500mg Tablet XR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Mexigliz M 60mg/500mg Tablet XR and seek immediate medical attention.
Prolonged use of Mexigliz M 60mg/500mg Tablet XR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Mexigliz M 60mg/500mg Tablet XR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol while taking Mexigliz M 60mg/500mg Tablet XR is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Mexigliz M 60mg/500mg XR tablets combine gliclazide and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mexigliz M 60mg/500mg Tablet XR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Mexigliz M 60mg/500mg Tablet XR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Mexigliz M 60mg/500mg Tablet XR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Mexigliz M 60mg/500mg Tablet XR and seek immediate medical attention.
Prolonged use of Mexigliz M 60mg/500mg Tablet XR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Mexigliz M 60mg/500mg Tablet XR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Mexigliz M 60mg/500mg Tablet XR is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Mexigliz M 60mg/500mg Tab...
73
MRP 85
14% off